Habitat escalated adaptive therapy (HEAT): a phase 2 trial utilizing radiomic habitat-directed and genomic-adjusted radiation dose (GARD) optimization for high-grade soft tissue sarcoma.
Saved in:
| Title: | Habitat escalated adaptive therapy (HEAT): a phase 2 trial utilizing radiomic habitat-directed and genomic-adjusted radiation dose (GARD) optimization for high-grade soft tissue sarcoma. |
|---|---|
| Authors: | Naghavi, Arash O.1 (AUTHOR) Arash.Naghavi@moffitt.org, Bryant, J. M.1 (AUTHOR), Kim, Youngchul2 (AUTHOR), Weygand, Joseph3 (AUTHOR), Redler, Gage1 (AUTHOR), Sim, Austin J.4 (AUTHOR), Miller, Justin1 (AUTHOR), Coucoules, Kaitlyn1 (AUTHOR), Michael, Lauren Taylor5 (AUTHOR), Gloria, Warren E.6 (AUTHOR), Yang, George1 (AUTHOR), Rosenberg, Stephen A.1 (AUTHOR), Ahmed, Kamran1 (AUTHOR), Bui, Marilyn M.6 (AUTHOR), Henderson-Jackson, Evita B.6 (AUTHOR), Lee, Andrew1 (AUTHOR), Lee, Caitlin D.1 (AUTHOR), Gonzalez, Ricardo J.7 (AUTHOR), Feygelman, Vladimir1 (AUTHOR), Eschrich, Steven A.2 (AUTHOR) |
| Source: | BMC Cancer. 4/9/2024, Vol. 24 Issue 1, p1-16. 16p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
